Bismuth Subnitrate EU Pharmacopoeia, Fisher Chemical™

Description

Pharmacopoeia reagents are intended for use in pharmacopoeia testing and monographs, produced under a GMP compliant ISO 9001 quality management system according to the relevant pharmacopoeia specification, using the pharmacopoeia reagent quality components and water meeting the relevant pharmacopoeia monograph requirement for Purified Water. Some pharmacopoeia standards are also accredited according to ISO 17025 and ISO Guide 43.

Specifications

• Concentration: 10μg/mL
• CAS: 28434-01-7
• Packaging: Ampoule
• Quantity: 500 mL
• Molecular Formula: C22H26O3
• InChI Key: VEMKTZHHVJILDY-UXHICEINSA-N
• SMILES: CC(=CC1C(C1(C)C)C(=O)OCC2=COC(=C2)CC3=CC=CC=C3)C
• IUPAC Name: (5-benzylfuran-3-yl)methyl (1R,3R)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropane-1-carboxylate
• Molecular Weight (g/mol): 338.447
• PubChem CID: 162381
• ChEBI: CHEBI:39280
• Grade: EU Ph Ref: 1011502
• Chemical Name or Material: Bismuth subnitrate solution.

Safety and Handling

Product Identifier

• Bismuth subnitrate solution. European Pharmacopoeia Ref: 1011502

Signal Word

• Warning

Hazard Category

• Serious eye damage/eye irritation Category 2
• Skin corrosion/irritation Category 2

Hazard Statement

• H315-Causes skin irritation.
• H319-Causes serious eye irritation.

Precautionary Statement

• P264-Wash hands, forearms andface thoroughly after handling.
• P280-Wear protective gloves/protective clothing/eye protection/face protection.
• P337+P313-If eye irritation persists: Get medical advice/attention.

Supplemental information

• MIXTURE LIST-Contains : nitric acid